Sentences with phrase «outcomes for patient risk»

Not exact matches

9:45 AM — 10:05 AM Discover Why Fast Company Named Omada the Most Innovative Company of the Year Meet Omada Health: With 87M consumers at risk of diabetes, 75,000 patients treated, 3 years of outcomes data, NetPromoter scores in the 90's, 70 + clients, and looming reimbursement by Medicare for its diabetes prevention online social network, -LSB-...]

Meet Omada Health: With 87M consumers at risk of diabetes, 75,000 patients treated, 3 years of outcomes data, NetPromoter scores in the 90's, 70 + clients, and looming reimbursement by Medicare for its diabetes prevention online social network, Omada has «cracked the code» on integrating consumer technology, medical coaching and big data at scale.

This evaluation, mandated by the Patient Protection and Affordable Care Act of 2010 (P.L. 111 - 148), is designed to build knowledge for policymakers and practitioners about the effectiveness of the MIECHV program in improving outcomes for at - risk children and families.

IF, as they claim, «home birth is safe as long as the patients are sufficiently low risk,» then how can you account for the increase in bad outcomes, which is now becoming undeniable?

The risk for poor patient outcomes increases as the risk of each component surgical procedure increases.

This is important because the proportion in which the de novo mutation is present in a patient, as well as the type of cells in which it occurs, may not only determine the clinical outcome of a disease for the patient, but also affect the risk of the parents having another child with the same disease in future pregnancies.

It explores topics such as risk, law and ethics; patient experience and treatment outcomes for cosmetic, transplantation, dental, fertility and weight loss surgery.

«There is a real risk that as clinics proliferate, if we don't address it in a more proactive way, as we see negative outcomes for patients grow and people get mixed bags of information about stem cells, then this could really negatively impact the public perception of this research.»

A large study of 108,711 patients who had cardiac surgery in Ontario, Canada, sought to identify risk factors for long - term stroke after surgery to improve outcomes for patients.

The five year disease - free and overall survival rates for patients with high - risk malignant germ cell tumours remains less than 50 %, and so accurate diagnosis and monitoring is crucial to improving outcomes for patients.

The study, entitled COMET (Comparison of Operative to Medical Endocrine Therapy) for low - risk ductal carcinoma in situ, received funding through a $ 13.4 million, five - year award from the Patient - Centered Outcomes Research Institute (PCORI), an independent, nonprofit organization authorized by Congress in 2010 to support research that enlightens health care decisions.

Her team's next step will be to understand whether certain patients are at higher risk for getting infected with rhinovirus in the first place and to ask if there are other risk factors for pneumonia and other poor outcomes from the infection.

As we are now able to focus our efforts on improving the overall patient experience and reducing the risk of relapse, the leading cause of death after transplant, we have greatly improved long - term survival outcomes for patients who before might not have had another treatment option.»

Researchers also contend that transplant outcomes can be further improved by identifying patients who are at high risk for certain complications, such as cognitive decline, or by employing post-transplant treatments to reduce their risk of relapse.

Historically, clinicians evaluating a patient for transplant have sought to identify donor cells that are perfectly matched to the patient's cell type, which is considered to be the optimal approach to help ensure successful outcomes and to minimize risk of graft - versus - host disease (GVHD), a serious and potentially life - threatening complication that occurs when the donated immune cells attack the patient's cells as foreign tissue.

Although some research has suggested that the use of the anticoagulant warfarin for atrial fibrillation among patients with chronic kidney disease would increase the risk of death or stroke, a study that included more than 24,000 patients found a lower l - year risk of the combined outcomes of death, heart attack or stroke without a higher risk of bleeding, according to a study in the March 5 issue of JAMA.

In a new study, a hospital surveillance program focusing on reducing the risks of sepsis, known as the two - stage Clinical Decision Support (CDS) system, was found to reduce the risk of adverse outcomes, such as death and hospice discharge for sepsis patients, by 30 % over the course of one year.

These data remind us that there are still patients, who fortunately very rarely, can develop life threatening complications following surgery and we still need to find surgical approaches that takes away these risks whilst retaining a successful outcome for patients.»

«While these observational data can not prove that treating patients based on the results of CTA testing will automatically result in better health outcomes, they do provide new information enabling a more informed choice of testing for patients with stable chest pain, especially for predicting future cardiovascular risk.»

The hospital's early recognition and treatment of sepsis resulted in a 30 % reduced risk of adverse outcomes for sepsis and severe sepsis patients, such as death or discharge to hospice.

The study reflects an «antimicrobial stewardship» approach, guiding healthcare providers to prescribe the most appropriate antibiotic for a patient's specific type of infection, with the aim of improving individual outcomes and reducing the overall risk of antibiotic resistance — in which disease - causing microorganisms develop resistance to commonly used antibiotics.

New research reports that cirrhosis at first diagnosis and antibodies for the soluble liver antigen / liver pancreas antigen (SLA / LP) are major risk factors for poor short - and long - term outcome in patients with autoimmune hepatitis.

«Cirrhosis, antibodies increase risk of poor outcome for autoimmune hepatitis patients.»

Patients of high - volume surgeons (75th percentile of yearly mesh - based procedures) had a significantly lower risk for experiencing the composite outcome (surgical procedures related to removal or revision of mesh slings).

«This suggests that altering transplantation dose could be a tool for improving outcomes for patients — promoting bone marrow engraftment, reducing the risk of infection and ultimately saving lives.»

The project aims to identify risk factors for patients and families with the goal of designing rehabilitation models to improve outcomes.

Efforts to improve patient outcomes, particularly for those with high - risk Group 4 medulloblastoma, have been hampered by the lack of accurate animal models.

For patients for whom radiotherapy is not suitable or feasible due to social circumstances, for whom the risk of late side effects of radiotherapy is high, or who have the prospect of a poor aesthetic outcome following BCT, a mastectomy may still be the preferable treatment optiFor patients for whom radiotherapy is not suitable or feasible due to social circumstances, for whom the risk of late side effects of radiotherapy is high, or who have the prospect of a poor aesthetic outcome following BCT, a mastectomy may still be the preferable treatment optifor whom radiotherapy is not suitable or feasible due to social circumstances, for whom the risk of late side effects of radiotherapy is high, or who have the prospect of a poor aesthetic outcome following BCT, a mastectomy may still be the preferable treatment optifor whom the risk of late side effects of radiotherapy is high, or who have the prospect of a poor aesthetic outcome following BCT, a mastectomy may still be the preferable treatment option.

Shorter consultation times have been linked to poorer health outcomes for patients and a heightened risk of burnout for doctors.

In 2009, practice leaders at Mayo Clinic initiated a practice redesign effort targeted at lower - risk cardiovascular surgical patients that would set clear expectations for their hospital care, improve patients» experiences and outcomes, and reduce overall costs.

New research from Mayo Clinic shows that implementing a uniform method to care for lower - risk cardiac surgical patients improves outcomes, reduces patients» time in the hospital and lowers overall per patient costs by 15 percent.

The researchers designed the study, called Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Coronary Artery Bypass Grafting Surgery (ERICCA), in an effort to find new ways to improve bypass outcomes for high - risk pOutcomes in Coronary Artery Bypass Grafting Surgery (ERICCA), in an effort to find new ways to improve bypass outcomes for high - risk poutcomes for high - risk patients.

TORONTO, May 12, 2016 — A new Canadian study focusing on caregiver outcomes of critically ill patients reveals that caregivers of intensive care unit (ICU) survivors, who have received mechanical ventilation for a minimum of seven days, are at a high risk of developing clinical depression persisting up to one year after discharge.

Renal outcomes with different fixed - dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomized controlled trial.

Follow - up for outcomes was done for patients who survived in first remission to the start of the fourth course without relapse and met low - risk classification criteria.

«If you make a poor decision using a telephone consultation, you potentially put the patient at risk for a poor outcome,» Meyer said.

The work that garnered the honor, «An analysis of the risk and benefit of neoadjuvant chemotherapy among patients undergoing surgery for non-small cell lung cancer,» examined data from more than 134,000 patients in the National Cancer Database to assess the impact of neoadjuvant therapy on perioperative outcomes, as well as long - term survival.

Finally, the study by Vera et al4 «demonstrates the power of combining clinical and molecular assessments in glioma studies to identify novel mechanisms underlying patient symptoms and toxicities for risk - stratification and interventions to improve patient outcomes.»

Prediction of short - and long - term outcomes by troponin T levels in low - risk patients evaluated for acute coronary syndromes

Patients with spatial neglect are more likely to experience poor rehabilitation outcomes, prolonged hospitalization, lower home return rates, and increased risks for injuries.

Acute myeloid leukemia (AML) is the leading cause of leukemia mortality in the United States.1 Curative treatment involves intensive induction chemotherapy, before proceeding to either consolidation chemotherapy or allogeneic stem cell transplantation based on the patient's risk for relapse.2 This approach has been employed for > 4 decades and, although most individuals achieve complete remissions with front - line therapy, 3 the majority of patients ultimately relapse with drug - resistant disease, and overall survival rates remain disappointingly poor.4 The limited ability of many patients to tolerate the intense chemotherapy - based treatments, in particular hematological toxicity, further contributes to the poor outcomes noted in this disease.

«If we were to find that increased dietary zinc impacts the outcome of C. diff infection in people, I think that official recommendations regarding how much zinc is consumed by certain patient populations would have to be reconsidered,» Skaar says, «particularly for those patients on antibiotics and at increased risk for C. diff infection.»

Although it is often suggested that children with epilepsy who are benefiting from ketogenic dietary therapy continue this for at least two years, duration of treatment could be shorter in patients with infantile spasms who become seizure - free; one study reported no adverse effect on seizure outcomes and less risk of growth disturbances when treatment was tapered down after 8 months (15).

By understanding a patient's family history and testing for inherited gene mutations, it is possible to uncover hereditary cancer risk — while there is still time to manage the risk and impact outcomes.

JAMA even recently published an article discussing its utility in weight loss and type 2 diabetes, both closely related to several common cancers like breast and prostate cancer.9 This effect, in itself, may improve cancer outcomes since weight gain is associated with an increased risk of recurrence and death, thus the mediccal should seriously consider the ketogenic diet, periodic ketosis, or simply low - carb to help patients achieve and maintain a healthy weight and healthy metabolic status.10 After years of taking continuous shots for their views, the modern day pioneers like Jeff Volek are finally receiving some vindication.

Little is known about the influence of treatment techniques based on DP on outcomes for patients classified as high psychosocial risk using the Subgroups for Targeted Treatment (STarT Back Screening Tool).

In terms of evidence - based physiotherapy practice, cognitive - behavioural approaches for patients at high psychosocial risk are the recommended management to improve patient treatment outcomes.

These interventions include nutrition, culinary techniques, physical activity, and stress management approaches of therapeutic yoga and behavioral health coaching to improve outcomes for patients at risk and those who already have common chronic diseases.

Nevertheless, healthy lifestyle modifications are possible with appropriate interventions, which include nutritional counseling, exercise training, and stress management techniques to improve outcomes for patients at risk and those who already have common chronic diseases.

Despite the potential for minor as well as severe postoperative phacoemulsification problems, the odds of obtaining a successful outcome still far outweigh the odds for failure in most cases, and as such, the surgery is well worth the cost, time commitment, and inherent risks for many owners, and in those patients that experience a positive outcome, the owners are typically extremely pleased.